Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association

VD Garovic, R Dechend, T Easterling… - …, 2022 - Am Heart Assoc
Hypertensive disorders of pregnancy (HDP) remain one of the major causes of pregnancy-
related maternal and fetal morbidity and mortality worldwide. Affected women are also at …

Adverse pregnancy outcomes and cardiovascular disease risk: unique opportunities for cardiovascular disease prevention in women: a scientific statement from the …

NI Parikh, JM Gonzalez, CAM Anderson, SE Judd… - Circulation, 2021 - Am Heart Assoc
This statement summarizes evidence that adverse pregnancy outcomes (APOs) such as
hypertensive disorders of pregnancy, preterm delivery, gestational diabetes, small-for …

Preeclampsia pathophysiology and adverse outcomes during pregnancy and postpartum

C Bisson, S Dautel, E Patel, S Suresh, P Dauer… - Frontiers in …, 2023 - frontiersin.org
Background Preeclampsia is a disease with far-reaching consequences that extend beyond
the immediate postpartum period and have a significant impact later in life. Preeclampsia …

Postpartum preeclampsia or eclampsia: defining its place and management among the hypertensive disorders of pregnancy

A Hauspurg, A Jeyabalan - American journal of obstetrics and gynecology, 2022 - Elsevier
High blood pressure in the postpartum period is most commonly seen in women with
antenatal hypertensive disorders, but it can develop de novo in the postpartum time frame …

Call to action: maternal health and saving mothers: a policy statement from the American Heart Association

LS Mehta, G Sharma, AA Creanga, AB Hameed… - Circulation, 2021 - Am Heart Assoc
The United States has the highest maternal mortality rates among developed countries, and
cardiovascular disease is the leading cause. Therefore, the American Heart Association has …

The value of remote monitoring for the COVID-19 pandemic

AR Watson, R Wah, R Thamman - Telemedicine and e-Health, 2020 - liebertpub.com
COVID-19 has created the need for population-level screening, and telemedicine is ideally
positioned to enable this. As telemedicine has evolved over the last decade, remote …

Cardiovascular disease screening in women: leveraging artificial intelligence and digital tools

DA Adedinsewo, AW Pollak, SD Phillips… - Circulation …, 2022 - Am Heart Assoc
Cardiovascular disease remains the leading cause of death in women. Given accumulating
evidence on sex-and gender-based differences in cardiovascular disease development and …

Opportunities in the postpartum period to reduce cardiovascular disease risk after adverse pregnancy outcomes: a scientific statement from the American Heart …

J Lewey, TM Beckie, HL Brown, SD Brown… - Circulation, 2024 - Am Heart Assoc
Adverse pregnancy outcomes are common among pregnant individuals and are associated
with long-term risk of cardiovascular disease. Individuals with adverse pregnancy outcomes …

Long-term cardiovascular disease risk in women after hypertensive disorders of pregnancy: recent advances in hypertension

K Khosla, S Heimberger, KM Nieman, A Tung… - …, 2021 - Am Heart Assoc
Patients with a history of hypertensive disorders of pregnancy (HDP) suffer higher rates of
long-term cardiovascular events including heart failure, coronary artery disease, and stroke …

Pregnancy as an early cardiovascular moment: peripartum cardiovascular health

SS Khan, NA Cameron, KJ Lindley - Circulation research, 2023 - Am Heart Assoc
Pregnancy is commonly referred to as a window into future CVH (cardiovascular health).
During pregnancy, physiological adaptations occur to promote the optimal growth and …